BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22187224)

  • 21. Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey.
    Nguyen C; Ranque B; Baubet T; Bérezné A; Mestre-Stanislas C; Rannou F; Papelard A; Morell-Dubois S; Revel M; Moro MR; Guillevin L; Poiraudeau S; Mouthon L;
    PLoS One; 2014; 9(2):e90484. PubMed ID: 24587375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study.
    Frech T; Hays RD; Maranian P; Clements PJ; Furst DE; Khanna D
    Rheumatology (Oxford); 2011 Jul; 50(7):1280-7. PubMed ID: 21324979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of cognitive function in systemic sclerosis patients: a pilot study.
    Khedr EM; El Fetoh NA; Gamal RM; Elzohri MH; Azoz NMA; Furst DE
    Clin Rheumatol; 2020 May; 39(5):1551-1559. PubMed ID: 31902028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study.
    Racine M; Hudson M; Baron M; Nielson WR;
    J Pain Symptom Manage; 2016 Jul; 52(1):43-53. PubMed ID: 26876159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatigue in systemic sclerosis: a systematic review.
    Basta F; Afeltra A; Margiotta DPE
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):150-160. PubMed ID: 29303706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools.
    Strickland G; Pauling J; Cavill C; McHugh N
    Clin Rheumatol; 2012 Aug; 31(8):1215-22. PubMed ID: 22588647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of systemic sclerosis in a district of northern Italy.
    Lo Monaco A; Bruschi M; La Corte R; Volpinari S; Trotta F
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S10-4. PubMed ID: 21586212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis.
    Sandqvist G; Hesselstrand R; Eberhardt K
    Scand J Rheumatol; 2009; 38(4):304-10. PubMed ID: 19296402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
    Nevskaya T; Baron M; Pope JE;
    Rheumatology (Oxford); 2017 Jul; 56(7):1111-1122. PubMed ID: 28340090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case-control study.
    Chan PT; Mok CC; Chan KL; Ho LY
    Clin Rheumatol; 2014 May; 33(5):659-66. PubMed ID: 24531870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort.
    Assassi S; Leyva AL; Mayes MD; Sharif R; Nair DK; Fischbach M; Nguyen N; Reveille JD; Gonzalez EB; McNearney TA;
    PLoS One; 2011; 6(10):e26061. PubMed ID: 22022507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomes.
    de Achaval S; Kallen MA; Mayes MD; Lopez-Olivo MA; Suarez-Almazor ME
    J Rheumatol; 2013 Aug; 40(8):1337-43. PubMed ID: 23772081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Turkish Version of Multidimensional Assessment of Fatigue and Fatigue Severity Scale is Reproducible and Correlated With Other Outcome Measures in Patients With Systemic Sclerosis.
    Gök K; Cengiz G; Erol K; Özgöçmen S
    Arch Rheumatol; 2016 Dec; 31(4):329-332. PubMed ID: 30375564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with quality of life in systemic sclerosis: a cross-sectional study.
    Sierakowska M; Doroszkiewicz H; Sierakowska J; Olesińska M; Grabowska-Jodkowska A; Brzosko M; Leszczyński P; Pawlak-Buś K; Batko B; Wiland P; Majdan M; Bykowska-Sochacka M; Romanowski W; Zon-Giebel A; Jeka S; Ndosi M
    Qual Life Res; 2019 Dec; 28(12):3347-3354. PubMed ID: 31482431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis.
    Nagy G; Dobrota R; Becker MO; Minier T; Varjú C; Kumánovics G; Distler O; Czirják L
    Arthritis Res Ther; 2023 May; 25(1):84. PubMed ID: 37210571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
    Kowal-Bielecka O; Avouac J; Pittrow D; Huscher D; Behrens F; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE; Distler O;
    J Rheumatol; 2011 Nov; 38(11):2419-27. PubMed ID: 21965635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey.
    Bassel M; Hudson M; Taillefer SS; Schieir O; Baron M; Thombs BD
    Rheumatology (Oxford); 2011 Apr; 50(4):762-7. PubMed ID: 21149249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study.
    Arias-Nuñez MC; Llorca J; Vazquez-Rodriguez TR; Gomez-Acebo I; Miranda-Filloy JA; Martin J; Gonzalez-Juanatey C; Gonzalez-Gay MA
    Medicine (Baltimore); 2008 Sep; 87(5):272-280. PubMed ID: 18794710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.